- Home
- VSEE vs FGEN Comparison
VSEE vs FGEN Comparison
Compare VSEE & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSEE
- FGEN
- Stock Information
- Founded
- VSEE 2008
- FGEN 1993
- Country
- VSEE United States
- FGEN United States
- Employees
- VSEE N/A
- FGEN N/A
- Industry
- VSEE
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- VSEE
- FGEN Health Care
- Exchange
- VSEE NYSE
- FGEN Nasdaq
- Market Cap
- VSEE 29.3M
- FGEN 33.5M
- IPO Year
- VSEE N/A
- FGEN 2014
- Fundamental
- Price
- VSEE $1.15
- FGEN $0.28
- Analyst Decision
- VSEE Strong Buy
- FGEN Strong Buy
- Analyst Count
- VSEE 1
- FGEN 1
- Target Price
- VSEE $5.00
- FGEN $10.00
- AVG Volume (30 Days)
- VSEE 51.9K
- FGEN 1.6M
- Earning Date
- VSEE 05-15-2025
- FGEN 05-05-2025
- Dividend Yield
- VSEE N/A
- FGEN N/A
- EPS Growth
- VSEE N/A
- FGEN N/A
- EPS
- VSEE N/A
- FGEN N/A
- Revenue
- VSEE $8,064,925.00
- FGEN $29,621,000.00
- Revenue This Year
- VSEE $76.10
- FGEN $544.98
- Revenue Next Year
- VSEE $64.83
- FGEN $9.45
- P/E Ratio
- VSEE N/A
- FGEN N/A
- Revenue Growth
- VSEE 37.45
- FGEN N/A
- 52 Week Low
- VSEE $1.10
- FGEN $0.18
- 52 Week High
- VSEE $33.08
- FGEN $1.82
- Technical
- Relative Strength Index (RSI)
- VSEE N/A
- FGEN 36.19
- Support Level
- VSEE N/A
- FGEN $0.28
- Resistance Level
- VSEE N/A
- FGEN $0.33
- Average True Range (ATR)
- VSEE 0.00
- FGEN 0.04
- MACD
- VSEE 0.00
- FGEN -0.00
- Stochastic Oscillator
- VSEE 0.00
- FGEN 6.96
About VSEE VSEE HEALTH INC
VSee Health Inc is a telehealth software platform. VSee's telemedicine solution, offering a fast, secure text + video collaboration app HIPAA messenger, and fully customizable virtual waiting rooms and clinics, is a complete telehealth platform that fits into any workflow. The VSee proprietary technology platform and modular software solution enable users to plug and play telehealth services with end-to-end encrypted video streaming integrated with patient metrics, electronic medical records, and other sensitive data, with multiple other interactive functionalities. The company's products include VSee Clinic, VSee Messenger, VSee APIs, VSee Remote patient monitoring, VSee Telehealth Staffing.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.